These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31778689)

  • 1. Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference.
    Collins D; Zhang Y; Blendy J; Kreek MJ
    Neuropharmacology; 2020 May; 167():107864. PubMed ID: 31778689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration.
    Zhang Y; Collins D; Butelman ER; Blendy JA; Kreek MJ
    Neuropharmacology; 2020 Dec; 181():108351. PubMed ID: 33031806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.
    Zhang Y; Picetti R; Butelman ER; Ho A; Blendy JA; Kreek MJ
    Neuropsychopharmacology; 2015 Mar; 40(5):1091-100. PubMed ID: 25336208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of OPRM1 (Mu-opioid Receptor Gene) A112G Polymorphism on Dual Oxycodone and Cocaine Self-administration Behavior in a Mouse Model.
    Zhang Y; Randesi M; Blendy JA; Kreek MJ; Butelman ER
    Neuroscience; 2024 Feb; 539():76-85. PubMed ID: 38211933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent oxycodone self administration alters subsequent oxycodone-induced conditioned place preference and anti-nociceptive effect in C57BL/6J mice in adulthood.
    Zhang Y; Windisch K; Altschuler J; Rahm S; Butelman ER; Kreek MJ
    Neuropharmacology; 2016 Dec; 111():314-322. PubMed ID: 27614221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
    Browne CA; Erickson RL; Blendy JA; Lucki I
    Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.
    Popova D; Desai N; Blendy JA; Pang ZP
    J Neurosci; 2019 Jul; 39(29):5685-5696. PubMed ID: 31109961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.
    Henderson-Redmond AN; Lowe TE; Tian XB; Morgan DJ
    Brain Res Bull; 2018 Apr; 138():12-19. PubMed ID: 28780411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalfurafine modulates the reinforcing effects of oxycodone in male and female adolescent C57BL/6J mice.
    Zhang Y; Kreek MJ
    Neuropharmacology; 2020 Oct; 176():108244. PubMed ID: 32702404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxycodone self-administration during pregnancy disrupts the maternal-infant dyad and decreases midbrain OPRM1 expression during early postnatal development in rats.
    Vassoler FM; Oranges ML; Toorie AM; Byrnes EM
    Pharmacol Biochem Behav; 2018 Oct; 173():74-83. PubMed ID: 30055180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu opioid receptors on vGluT2-expressing glutamatergic neurons modulate opioid reward.
    Reeves KC; Kube MJ; Grecco GG; Fritz BM; Muñoz B; Yin F; Gao Y; Haggerty DL; Hoffman HJ; Atwood BK
    Addict Biol; 2021 May; 26(3):e12942. PubMed ID: 32686251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxycodone injections not paired with conditioned place preference have little effect on the hippocampal opioid system in female and male rats.
    Ashirova E; Contoreggi NH; Johnson MA; Al-Khayat FJ; Calcano GA; Rubin BR; O'Cinneide EM; Zhang Y; Zhou Y; Gregoire L; McEwen BS; Kreek MJ; Milner TA
    Synapse; 2021 Jan; 75(1):e22182. PubMed ID: 32654187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of the μ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G.
    Wang YJ; Huang P; Ung A; Blendy JA; Liu-Chen LY
    Neuroscience; 2012 Mar; 205():178-84. PubMed ID: 22240251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship of OPRM1 118A/G gene polymorphism and oxycodone analygesic dose in paitents with cancer pain].
    Lin T; Li X; Song J; Zhang C; Bie M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):887-890. PubMed ID: 30512171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral effects of neonatal opioid exposure in mice: Influence of the OPRM1 SNP.
    Robinson SA; Jones AD; Brynildsen JK; Ehrlich ME; Blendy JA
    Addict Biol; 2020 Sep; 25(5):e12806. PubMed ID: 31267641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.
    Hall FS; Goeb M; Li XF; Sora I; Uhl GR
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):123-30. PubMed ID: 14969743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
    Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
    J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line.
    Bryant CD; Guido MA; Kole LA; Cheng R
    Addict Biol; 2014 Jul; 19(4):552-61. PubMed ID: 23231598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Mu Opioid Receptors in High Fat Diet-Induced Reward and Potentiation of the Rewarding Effect of Oxycodone.
    Iqbal A; Hamid A; Ahmad SM; Lutfy K
    Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.
    Pu J; Wang N; Huang ZK; He XY; Yuan HB
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9393-9410. PubMed ID: 31773688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.